data_2ofh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ofh _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 CA--C 1.532 0.406 0 CA-C-O 119.277 -0.384 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' X' X ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.82 138.69 33.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.685 1.194 . . . . 0.0 110.054 164.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 8' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -93.51 139.01 31.22 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 125.232 1.413 . . . . 0.0 113.102 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -97.22 146.9 24.65 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.548 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -159.45 143.14 14.71 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.213 1.805 . . . . 0.0 108.97 -162.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -129.19 137.06 50.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.583 1.153 . . . . 0.0 112.817 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 12' ' ' MET . . . . . . . . . . . . . 5.0 ptp -104.81 169.48 8.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.415 1.486 . . . . 0.0 112.529 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 13' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -98.75 154.59 17.87 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.172 0.989 . . . . 0.0 110.12 164.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -143.66 140.79 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.4 1.08 . . . . 0.0 109.979 -160.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.74 -12.78 63.78 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.005 -1.442 . . . . 0.0 116.584 -170.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.25 19.95 0.05 OUTLIER Glycine 0 CA--C 1.536 1.364 0 N-CA-C 119.419 2.528 . . . . 0.0 119.419 -173.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.26 95.48 0.3 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.133 1.466 . . . . 0.0 110.89 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.52 174.61 0.21 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.075 1.75 . . . . 0.0 111.664 149.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 19' ' ' CYS . . . . . . . . . . . . . 45.8 t -97.43 -62.6 1.23 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.169 1.388 . . . . 0.0 109.555 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -34.8 -42.6 0.16 Allowed 'General case' 0 N--CA 1.475 0.801 1 C-N-CA 131.803 4.041 . . . . 0.0 114.468 -172.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -156.3 65.02 0.55 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.102 1.361 . . . . 0.0 110.324 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 22' ' ' CYS . . . . . 0.603 ' HA ' ' HE2' ' X' ' 25' ' ' LYS . 0.1 OUTLIER -165.29 -44.81 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 117.251 -1.357 . . . . 0.0 113.587 -173.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' X' X ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -49.49 68.05 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.919 1.236 . . . . 0.0 109.816 168.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.2 -49.67 68.86 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.329 1.452 . . . . 0.0 112.669 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' X' ' 22' ' ' CYS . 36.3 mtmt -65.56 -21.26 66.58 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -172.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 26' ' ' ILE . . . . . . . . . . . . . 47.2 mm -76.39 -71.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.935 0.894 . . . . 0.0 109.742 163.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 27' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -59.28 -47.08 86.73 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.592 1.157 . . . . 0.0 111.14 -156.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.52 9.84 57.39 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -90.51 -48.51 7.05 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.903 1.352 . . . . 0.0 110.972 157.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 30' ' ' LEU . . . . . . . . . . . . . 62.0 mt -50.55 -37.98 42.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.115 1.766 . . . . 0.0 114.492 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 31' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -55.63 -39.54 70.98 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.768 0.713 . . . . 0.0 112.071 174.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.85 -9.8 56.4 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.769 0.828 . . . . 0.0 112.871 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 33' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.94 179.29 7.92 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 122.177 0.989 . . . . 0.0 110.62 168.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 34' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -115.83 162.59 17.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.877 1.271 . . . . 0.0 109.428 -172.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.81 -32.28 2.7 Favored Glycine 0 N--CA 1.474 1.167 0 O-C-N 120.017 -1.677 . . . . 0.0 114.34 166.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -94.09 144.44 9.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 124.835 1.254 . . . . 0.0 109.523 167.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.5 -10.1 1.42 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -129.95 159.4 36.79 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.376 0.989 . . . . 0.0 109.303 160.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 39' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' X' ' 50' ' ' VAL . . . -160.69 172.94 16.2 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.964 -0.46 . . . . 0.0 111.617 163.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 40' ' ' SER . . . . . . . . . . . . . 3.6 m -175.15 142.95 0.66 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.217 1.807 . . . . 0.0 112.729 163.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 41' ' ' VAL . . . . . . . . . . . . . 12.1 m -75.98 152.01 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 120.17 -1.581 . . . . 0.0 114.512 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 42' ' ' THR . . . . . . . . . . . . . 56.4 m -125.7 67.51 1.17 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.774 2.03 . . . . 0.0 107.837 162.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 43' ' ' VAL . . . . . . . . . . . . . 25.5 t -56.18 -32.52 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 125.722 1.609 . . . . 0.0 111.079 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.6 7.24 0.16 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.864 1.666 . . . . 0.0 115.048 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -146.69 6.22 0.92 Allowed 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.093 -1.004 . . . . 0.0 110.835 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.81 55.36 31.3 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -168.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 47' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -136.28 153.48 51.17 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.367 1.067 . . . . 0.0 112.154 -177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 48' ' ' LEU . . . . . . . . . . . . . 21.7 mt -126.74 131.72 51.27 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.386 1.075 . . . . 0.0 109.33 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 49' ' ' THR . . . . . . . . . . . . . 43.5 m -100.43 139.46 36.07 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.536 1.135 . . . . 0.0 109.222 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 50' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' X' ' 39' ' ' ALA . 24.0 m -132.62 156.83 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.956 1.302 . . . . 0.0 110.265 168.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 51' ' ' THR . . . . . . . . . . . . . 4.0 m -122.4 119.51 31.22 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.555 0.535 . . . . 0.0 111.125 156.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.26 142.56 47.36 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -172.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 53' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -92.86 110.0 42.84 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.554 1.941 . . . . 0.0 109.76 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 54' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -79.07 33.65 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.904 3.069 . . . . 0.0 113.362 -165.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 55' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -86.72 -22.78 25.81 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 56' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -149.94 -79.53 0.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.926 1.239 . . . . 0.0 111.643 -171.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 57' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.27 148.53 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.028 1.731 . . . . 0.0 108.687 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 58' ' ' SER . . . . . . . . . . . . . 44.6 t -143.04 -108.19 0.13 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.708 1.203 . . . . 0.0 108.403 -167.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 59' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' X' ' 59' ' ' GLU . 3.3 mp0 -53.59 -34.01 56.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.125 1.33 . . . . 0.0 112.853 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 60' ' ' ILE . . . . . . . . . . . . . 28.4 mm -41.94 -57.44 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.5 1.92 . . . . 0.0 111.17 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.08 -38.08 1.57 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 128.77 2.828 . . . . 0.0 113.969 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 62' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.18 -31.47 4.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.757 1.223 . . . . 0.0 110.928 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -64.86 -49.39 70.74 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.675 1.19 . . . . 0.0 112.102 171.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.7 -48.33 63.56 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 170.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 65' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -73.58 -43.64 59.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -170.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 66' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.54 -43.43 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.267 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.87 76.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.431 1.014 . . . . 0.0 112.877 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.45 0.24 2.3 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 69' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.4 -0.03 12.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.828 1.251 . . . . 0.0 112.893 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.41 8.16 81.38 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.628 1.108 . . . . 0.0 114.732 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 71' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -99.79 171.55 7.81 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.685 1.242 . . . . 0.0 112.803 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 72' ' ' THR . . . . . . . . . . . . . 1.5 p -113.33 152.48 29.87 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 127.588 2.355 . . . . 0.0 110.836 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -135.64 154.24 51.37 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.321 1.848 . . . . 0.0 111.645 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.81 84.1 1.92 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.553 1.141 . . . . 0.0 110.203 171.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 75' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -80.77 128.34 72.07 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.461 174.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.45 -1.088 0 C-N-CA 123.447 2.765 . . . . 0.0 109.534 171.047 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 CA--C 1.532 0.406 0 CA-C-O 119.277 -0.384 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' X' X ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.82 138.69 33.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.685 1.194 . . . . 0.0 110.054 164.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 8' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -93.51 139.01 31.22 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 125.232 1.413 . . . . 0.0 113.102 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -97.22 146.9 24.65 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.548 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -159.45 143.14 14.71 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.213 1.805 . . . . 0.0 108.97 -162.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -129.19 137.06 50.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.583 1.153 . . . . 0.0 112.817 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 12' ' ' MET . . . . . . . . . . . . . 5.0 ptp -104.81 169.48 8.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.415 1.486 . . . . 0.0 112.529 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 13' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -98.75 154.59 17.87 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.172 0.989 . . . . 0.0 110.12 164.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -143.66 140.79 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.4 1.08 . . . . 0.0 109.979 -160.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.74 -12.78 63.78 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.005 -1.442 . . . . 0.0 116.584 -170.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.25 19.95 0.05 OUTLIER Glycine 0 CA--C 1.536 1.364 0 N-CA-C 119.419 2.528 . . . . 0.0 119.419 -173.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.26 95.48 0.3 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.133 1.466 . . . . 0.0 110.89 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.52 174.61 0.21 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.075 1.75 . . . . 0.0 111.664 149.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 19' ' ' CYS . . . . . . . . . . . . . 45.8 t -97.43 -62.6 1.23 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.169 1.388 . . . . 0.0 109.555 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -34.8 -42.6 0.16 Allowed 'General case' 0 N--CA 1.475 0.801 1 C-N-CA 131.803 4.041 . . . . 0.0 114.468 -172.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -156.3 65.02 0.55 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.102 1.361 . . . . 0.0 110.324 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 22' ' ' CYS . . . . . 0.661 ' HA ' ' HE2' ' X' ' 25' ' ' LYS . 0.1 OUTLIER -165.29 -44.81 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 117.251 -1.357 . . . . 0.0 113.587 -173.519 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' X' X ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -49.49 68.05 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.919 1.236 . . . . 0.0 109.816 168.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 24' ' ' LEU . . . . . 0.401 ' H ' HD23 ' X' ' 24' ' ' LEU . 0.1 OUTLIER -54.2 -49.67 68.86 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.329 1.452 . . . . 0.0 112.669 177.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' X' X ' 25' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' X' ' 22' ' ' CYS . 36.3 mtmt -65.56 -21.26 66.58 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -172.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 26' ' ' ILE . . . . . . . . . . . . . 47.2 mm -76.39 -71.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.935 0.894 . . . . 0.0 109.742 163.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 27' ' ' GLU . . . . . 0.491 ' CD ' HG13 ' X' ' 41' ' ' VAL . 27.1 mt-10 -59.28 -47.08 86.73 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.592 1.157 . . . . 0.0 111.14 -156.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.52 9.84 57.39 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -90.51 -48.51 7.05 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.903 1.352 . . . . 0.0 110.972 157.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 30' ' ' LEU . . . . . . . . . . . . . 62.0 mt -50.55 -37.98 42.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.115 1.766 . . . . 0.0 114.492 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 31' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -55.63 -39.54 70.98 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.768 0.713 . . . . 0.0 112.071 174.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.85 -9.8 56.4 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.769 0.828 . . . . 0.0 112.871 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 33' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.94 179.29 7.92 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 122.177 0.989 . . . . 0.0 110.62 168.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 34' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -115.83 162.59 17.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.877 1.271 . . . . 0.0 109.428 -172.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.81 -32.28 2.7 Favored Glycine 0 N--CA 1.474 1.167 0 O-C-N 120.017 -1.677 . . . . 0.0 114.34 166.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -94.09 144.44 9.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 124.835 1.254 . . . . 0.0 109.523 167.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.5 -10.1 1.42 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -129.95 159.4 36.79 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.376 0.989 . . . . 0.0 109.303 160.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 39' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' X' ' 50' ' ' VAL . . . -160.69 172.94 16.2 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.964 -0.46 . . . . 0.0 111.617 163.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 40' ' ' SER . . . . . . . . . . . . . 3.6 m -175.15 142.95 0.66 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.217 1.807 . . . . 0.0 112.729 163.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 41' ' ' VAL . . . . . 0.688 HG12 ' CD2' ' X' ' 48' ' ' LEU . 12.1 m -75.98 152.01 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 120.17 -1.581 . . . . 0.0 114.512 176.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 42' ' ' THR . . . . . . . . . . . . . 56.4 m -125.7 67.51 1.17 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.774 2.03 . . . . 0.0 107.837 162.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 43' ' ' VAL . . . . . . . . . . . . . 25.5 t -56.18 -32.52 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 125.722 1.609 . . . . 0.0 111.079 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.6 7.24 0.16 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.864 1.666 . . . . 0.0 115.048 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -146.69 6.22 0.92 Allowed 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.093 -1.004 . . . . 0.0 110.835 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.81 55.36 31.3 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -168.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 47' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -136.28 153.48 51.17 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.367 1.067 . . . . 0.0 112.154 -177.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 48' ' ' LEU . . . . . 0.688 ' CD2' HG12 ' X' ' 41' ' ' VAL . 21.7 mt -126.74 131.72 51.27 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.386 1.075 . . . . 0.0 109.33 173.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 49' ' ' THR . . . . . . . . . . . . . 43.5 m -100.43 139.46 36.07 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.536 1.135 . . . . 0.0 109.222 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 50' ' ' VAL . . . . . 0.458 HG21 HD11 ' X' ' 62' ' ' ILE . 24.0 m -132.62 156.83 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.956 1.302 . . . . 0.0 110.265 168.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 51' ' ' THR . . . . . . . . . . . . . 4.0 m -122.4 119.51 31.22 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.555 0.535 . . . . 0.0 111.125 156.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.26 142.56 47.36 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -172.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 53' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -92.86 110.0 42.84 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.554 1.941 . . . . 0.0 109.76 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 54' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -79.07 33.65 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.904 3.069 . . . . 0.0 113.362 -165.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 55' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -86.72 -22.78 25.81 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 56' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -149.94 -79.53 0.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.926 1.239 . . . . 0.0 111.643 -171.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 57' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.27 148.53 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.028 1.731 . . . . 0.0 108.687 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 58' ' ' SER . . . . . . . . . . . . . 44.6 t -143.04 -108.19 0.13 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.708 1.203 . . . . 0.0 108.403 -167.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 59' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' X' ' 59' ' ' GLU . 3.3 mp0 -53.59 -34.01 56.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.125 1.33 . . . . 0.0 112.853 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 60' ' ' ILE . . . . . . . . . . . . . 28.4 mm -41.94 -57.44 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.5 1.92 . . . . 0.0 111.17 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.08 -38.08 1.57 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 128.77 2.828 . . . . 0.0 113.969 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 62' ' ' ILE . . . . . 0.458 HD11 HG21 ' X' ' 50' ' ' VAL . 0.3 OUTLIER -92.18 -31.47 4.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.757 1.223 . . . . 0.0 110.928 -176.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' X' X ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -64.86 -49.39 70.74 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.675 1.19 . . . . 0.0 112.102 171.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.7 -48.33 63.56 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 170.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 65' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -73.58 -43.64 59.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -170.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 66' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.54 -43.43 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.267 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.87 76.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.431 1.014 . . . . 0.0 112.877 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.45 0.24 2.3 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 69' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.4 -0.03 12.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.828 1.251 . . . . 0.0 112.893 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.41 8.16 81.38 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.628 1.108 . . . . 0.0 114.732 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 71' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -99.79 171.55 7.81 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.685 1.242 . . . . 0.0 112.803 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 72' ' ' THR . . . . . . . . . . . . . 1.5 p -113.33 152.48 29.87 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 127.588 2.355 . . . . 0.0 110.836 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -135.64 154.24 51.37 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.321 1.848 . . . . 0.0 111.645 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.81 84.1 1.92 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.553 1.141 . . . . 0.0 110.203 171.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 75' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -80.77 128.34 72.07 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.461 174.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.45 -1.088 0 C-N-CA 123.447 2.765 . . . . 0.0 109.534 171.047 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 CA--C 1.532 0.406 0 CA-C-O 119.277 -0.384 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' X' X ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.82 138.69 33.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.685 1.194 . . . . 0.0 110.054 164.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 8' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -93.51 139.01 31.22 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 125.232 1.413 . . . . 0.0 113.102 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -97.22 146.9 24.65 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.548 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -159.45 143.14 14.71 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.213 1.805 . . . . 0.0 108.97 -162.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 11' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -129.19 137.06 50.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.583 1.153 . . . . 0.0 112.817 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 12' ' ' MET . . . . . . . . . . . . . 5.0 ptp -104.81 169.48 8.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.415 1.486 . . . . 0.0 112.529 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 13' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -98.75 154.59 17.87 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.172 0.989 . . . . 0.0 110.12 164.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -143.66 140.79 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.4 1.08 . . . . 0.0 109.979 -160.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.74 -12.78 63.78 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.005 -1.442 . . . . 0.0 116.584 -170.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.25 19.95 0.05 OUTLIER Glycine 0 CA--C 1.536 1.364 0 N-CA-C 119.419 2.528 . . . . 0.0 119.419 -173.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.26 95.48 0.3 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.133 1.466 . . . . 0.0 110.89 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.52 174.61 0.21 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.075 1.75 . . . . 0.0 111.664 149.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 19' ' ' CYS . . . . . . . . . . . . . 45.8 t -97.43 -62.6 1.23 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.169 1.388 . . . . 0.0 109.555 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -34.8 -42.6 0.16 Allowed 'General case' 0 N--CA 1.475 0.801 1 C-N-CA 131.803 4.041 . . . . 0.0 114.468 -172.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 21' ' ' SER . . . . . . . . . . . . . 10.2 m -156.3 65.02 0.55 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.102 1.361 . . . . 0.0 110.324 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 22' ' ' CYS . . . . . 0.661 ' HA ' ' HE2' ' X' ' 25' ' ' LYS . 0.1 OUTLIER -165.29 -44.81 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 117.251 -1.357 . . . . 0.0 113.587 -173.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' X' X ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -49.49 68.05 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.919 1.236 . . . . 0.0 109.816 168.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 24' ' ' LEU . . . . . 0.401 ' H ' HD23 ' X' ' 24' ' ' LEU . 0.1 OUTLIER -54.2 -49.67 68.86 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.329 1.452 . . . . 0.0 112.669 177.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' X' ' 22' ' ' CYS . 36.3 mtmt -65.56 -21.26 66.58 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -172.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 26' ' ' ILE . . . . . . . . . . . . . 47.2 mm -76.39 -71.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.935 0.894 . . . . 0.0 109.742 163.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 27' ' ' GLU . . . . . 0.491 ' CD ' HG13 ' X' ' 41' ' ' VAL . 27.1 mt-10 -59.28 -47.08 86.73 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.592 1.157 . . . . 0.0 111.14 -156.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.52 9.84 57.39 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -90.51 -48.51 7.05 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.903 1.352 . . . . 0.0 110.972 157.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 30' ' ' LEU . . . . . . . . . . . . . 62.0 mt -50.55 -37.98 42.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.115 1.766 . . . . 0.0 114.492 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 31' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -55.63 -39.54 70.98 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.768 0.713 . . . . 0.0 112.071 174.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.85 -9.8 56.4 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.769 0.828 . . . . 0.0 112.871 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 33' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.94 179.29 7.92 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 122.177 0.989 . . . . 0.0 110.62 168.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 34' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -115.83 162.59 17.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.877 1.271 . . . . 0.0 109.428 -172.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.81 -32.28 2.7 Favored Glycine 0 N--CA 1.474 1.167 0 O-C-N 120.017 -1.677 . . . . 0.0 114.34 166.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -94.09 144.44 9.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 124.835 1.254 . . . . 0.0 109.523 167.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.5 -10.1 1.42 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -129.95 159.4 36.79 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.376 0.989 . . . . 0.0 109.303 160.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 39' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' X' ' 50' ' ' VAL . . . -160.69 172.94 16.2 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.964 -0.46 . . . . 0.0 111.617 163.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 40' ' ' SER . . . . . . . . . . . . . 3.6 m -175.15 142.95 0.66 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.217 1.807 . . . . 0.0 112.729 163.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 41' ' ' VAL . . . . . 0.688 HG12 ' CD2' ' X' ' 48' ' ' LEU . 12.1 m -75.98 152.01 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 120.17 -1.581 . . . . 0.0 114.512 176.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 42' ' ' THR . . . . . . . . . . . . . 56.4 m -125.7 67.51 1.17 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.774 2.03 . . . . 0.0 107.837 162.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 43' ' ' VAL . . . . . . . . . . . . . 25.5 t -56.18 -32.52 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 125.722 1.609 . . . . 0.0 111.079 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.6 7.24 0.16 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.864 1.666 . . . . 0.0 115.048 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -146.69 6.22 0.92 Allowed 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.093 -1.004 . . . . 0.0 110.835 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.81 55.36 31.3 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -168.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 47' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -136.28 153.48 51.17 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.367 1.067 . . . . 0.0 112.154 -177.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 48' ' ' LEU . . . . . 0.688 ' CD2' HG12 ' X' ' 41' ' ' VAL . 21.7 mt -126.74 131.72 51.27 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.386 1.075 . . . . 0.0 109.33 173.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 49' ' ' THR . . . . . . . . . . . . . 43.5 m -100.43 139.46 36.07 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.536 1.135 . . . . 0.0 109.222 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 50' ' ' VAL . . . . . 0.458 HG21 HD11 ' X' ' 62' ' ' ILE . 24.0 m -132.62 156.83 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.956 1.302 . . . . 0.0 110.265 168.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 51' ' ' THR . . . . . . . . . . . . . 4.0 m -122.4 119.51 31.22 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.555 0.535 . . . . 0.0 111.125 156.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.26 142.56 47.36 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -172.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 53' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -92.86 110.0 42.84 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.554 1.941 . . . . 0.0 109.76 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 54' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -79.07 33.65 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.904 3.069 . . . . 0.0 113.362 -165.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 55' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -86.72 -22.78 25.81 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 56' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -149.94 -79.53 0.13 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.926 1.239 . . . . 0.0 111.643 -171.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 57' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.27 148.53 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.028 1.731 . . . . 0.0 108.687 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 58' ' ' SER . . . . . . . . . . . . . 44.6 t -143.04 -108.19 0.13 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.708 1.203 . . . . 0.0 108.403 -167.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 59' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' X' ' 59' ' ' GLU . 3.3 mp0 -53.59 -34.01 56.89 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.125 1.33 . . . . 0.0 112.853 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 60' ' ' ILE . . . . . . . . . . . . . 28.4 mm -41.94 -57.44 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.5 1.92 . . . . 0.0 111.17 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.08 -38.08 1.57 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 128.77 2.828 . . . . 0.0 113.969 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 62' ' ' ILE . . . . . 0.458 HD11 HG21 ' X' ' 50' ' ' VAL . 0.3 OUTLIER -92.18 -31.47 4.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.757 1.223 . . . . 0.0 110.928 -176.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' X' X ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -64.86 -49.39 70.74 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.675 1.19 . . . . 0.0 112.102 171.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.7 -48.33 63.56 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 170.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 65' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -73.58 -43.64 59.27 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -170.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 66' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.54 -43.43 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.267 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.87 76.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.431 1.014 . . . . 0.0 112.877 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.45 0.24 2.3 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 69' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.4 -0.03 12.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.828 1.251 . . . . 0.0 112.893 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.41 8.16 81.38 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.628 1.108 . . . . 0.0 114.732 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 71' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -99.79 171.55 7.81 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.685 1.242 . . . . 0.0 112.803 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 72' ' ' THR . . . . . . . . . . . . . 1.5 p -113.33 152.48 29.87 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 127.588 2.355 . . . . 0.0 110.836 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -135.64 154.24 51.37 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.321 1.848 . . . . 0.0 111.645 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.81 84.1 1.92 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.553 1.141 . . . . 0.0 110.203 171.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 75' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -80.77 128.34 72.07 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.461 174.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 N--CA 1.45 -1.088 0 C-N-CA 123.447 2.765 . . . . 0.0 109.534 171.047 . . . . . . . . 0 0 . 1 stop_ save_